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A B S T R A C T
Bovine leukemia virus (BLV) is one of the most important virus in dairy cattle. The infection behavior follows
what we call the iceberg phenomenon: 60% of infected animals do not show clinical signs; 30% develop per-
sistent lymphocytosis (PL); and the remaining 10%, die due to lymphosarcoma. BLV transmission depends on
infected cell exchange and thus, proviral load is determinant. Understanding the mechanisms by which cattle
governs the control of viral dissemination will be desirable for designing effective therapeutic or preventive
strategies for BLV. The development of high proviral load (HPL) or low proviral load (LPL) might be associated
to genetic factors and humoral immune responses, however cellular responses are not fully described. It is known
that BLV affects cellular homeostasis: proliferation and apoptosis. It is also known that the BLV tropism is
directed towards B lymphocytes, and that lymphocytotic animals have elevated amounts of these cells. Usually,
when an animal is infected by BLV, the B markers that increase are CD21, CD5 and CD11b. This increase could
be related to the modulation of apoptosis in these cells. This is the first work in which animals infected with BLV
are classified according to their proviral load and the subpopulations of B and T lymphocytes are evaluated in
terms of their percentage in peripheral blood and its stage of apoptosis and viability. PBMCs from HPL animals
proliferated more than LPL and non-infected animals. CD11b+/CD5+ lymphocytes in LPL animals presented
greater early and late apoptosis than HPL animals and cells of HPL animals had increased viability than LPL
animals. Our results confirm that BLV alters the mechanism of apoptosis and proliferation of infected cells.
1. Introduction
Bovine leukemia virus (BLV) is a deltaretrovirus, the most wide-
spread pathogen in dairy cattle. It is the etiological agent of enzootic
bovine leukemia (EBL), a disease characterized by three different pre-
sentations: asymptomatic or aleukemic (AL), persistent lymphocytosis
(PL), and leukemia or lymphoma (Bartlett et al., 2013). Approximately
30% of infected animals will develop PL, while 0.1–10% of infected
animals will develop either leukemia or lymphoma (Kabeya et al.,
2001). PL stage is characterized by a polyclonal B-cell expansion that
occurs almost exclusively within the CD5+ B-cell subset, which are in
turn the primary target for BLV proviral integration. This accumulation
of B-lymphocytes in blood and lymphoid tissue potentially cause leu-
kemia/lymphoma, especially in PL cattle (Gillet et al., 2007; Florins
et al., 2007).
BLV transmission occurs by exchange of cells harboring the virus, so
the number of infected cells in the animal is crucial (Hopkins and
DiGiacomo, 1997). Even though PL cattle are considered the most risky
for transmission, asymptomatic animals may also play a role depending
on their proviral load (Juliarena et al., 2007). In fact, approximately
60% of the AL animals present low proviral load (LPL), while the re-
maining 40% will be AL animals with high proviral load (HPL)
(Juliarena et al., 2007). The ability to control viral spread in infected
animals could be associated in part to host genetic factors, such as
polymorphisms in the bovine leukocyte antigen (BoLA) gene (Juliarena
et al., 2008; Polat et al., 2015) and the promoter region of tumor ne-
crosis factor-alpha (TNF-α) gene (Lendez et al., 2015). However, these
factors cannot fully explain LPL profile. Even though humoral immune
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responses were described (Juliarena et al., 2007), cellular response
against the virus has not been well characterized in animals that de-
velop LPL or HPL. Most of the studies carried out the cell dynamics in
BLV-infected ewes as a model, nonetheless there is great difference
between cattle and ewes in BLV-infection (Florins et al., 2007). To the
best of our knowledge, no study has been carried out yet on lymphocyte
proliferation and apoptosis of different lymphocyte subpopulations in
dairy cows infected with BLV with distinct proviral loads.
BLV infection alters immunological mechanisms, mainly affecting B-
lymphocytes; moreover, BLV can also infect and alter other cell types,
particularly T-cells (Gillet et al., 2007; Florins et al., 2007; Kabeya
et al., 2001; Frie and Coussens, 2015). While polyclonal proliferation of
B-cells is likely one factor leading to dramatic alterations in the relative
percent of other cell types in peripheral blood mononuclear cells
(PBMCs), other factors must be considered, such as the rate of pro-
liferation and apoptosis in various immune cells. Evidence in the lit-
erature suggest that both cellular proliferation and apoptosis rates are
altered in BLV-infected cattle, though there is no consensus on the di-
rection of these changes (Klener et al., 2006; Erskine et al., 2011; Souza
et al., 2011; Frie and Coussens, 2015).
To deepen our knowledge on BLV effects on immune lymphocyte
responses, our study attempts to explore the proliferation and apoptosis
of distinct lymphocyte subpopulations in clinically healthy BLV-in-
fected cows that sustained different proviral load profiles.
2. Materials and methods
2.1. Animals
Twenty-four adult Holstein dairy cattle were used: eight animals
were classified as BLV-negative or uninfected and 16 animals were
classified as BLV-positive animals using the ELISA 108 (Gutierrez et al.,
2001). All lactating dairy cows were clinically healthy and between the
second and third lactations. Cows around parturition were excluded.
The proviral load was determined by real-time PCR as described pre-
viously (Farias et al., 2016) and evaluated two times at six-month in-
tervals before classifying BLV-positive animals into the high proviral
load, HPL, n=8 (>1000 BLV copies/reaction) or into the low proviral
load, LPL, n=8 (<100 BLV copies/reaction) group. Once animals
were re-tested and classified into the different groups, trials were car-
ried out.
2.2. PBMCs culture and proliferation assay
Peripheral venous blood samples were collected in tubes containing
sodium citrate/EDTA. PBMCs were isolated by Ficoll-Paque™ PLUS
density gradient (GE Healthcare, Sigma-Aldrich, Darmstadt, Germany).
PBMCs were suspended in RMPI 1640 (Gibco, Thermo Fisher,
Massachusetts, USA) with 10% heat-inactivated fetal calf serum (FCS)
supplemented with penicillin and streptomycin. PBMCs (3×10⁵cells
per well) were cultured for 48 h in triplicate wells of 96-well culture
cluster (Corning, USA) in the presence of different mitogens:
Concanavalin A (ConA, Sigma-Aldrich, Darmstadt, Germany; 10 ng/
1×10⁶PBMCs), lipopolysaccharides from Escherichia coli 026:B6 (LPS,
Sigma-Aldrich, Darmstadt, Germany; 19 μg/1× 10⁶PBMCs), Pokeweed
mitogen (PWM, Sigma-Aldrich, Darmstadt, Germany; 100 ng/1× 10⁶
PBMCs), or without mitogen (control cells). Con-A was used for mi-
thogen-induce proliferation of T lymphocytes (Soder and Holden, 1999;
Mehrzad and Zhao, 2008), LPS was used to induce B cells (Mond and
Brunswick, 2003; Mehrzad and Zhao, 2008; Latorre et al., 2009), and
PWM was used to induce both T- and B- cells (Vries et al., 1980).
The methodology used for cell proliferation assay was similar to that
described by Erskine et al., (2011), but with modifications in mitogens
concentration, cell culture conditions and metabolite quantification.
We measured cell proliferation by 3-(4,5 dimethylthiazol-2-yl) 2,5di-
phenyltetrazole (MTT, Sigma-Aldrich, Darmstadt, Germany) reduction
assay, quantifying the absorbance of formazan crystals in a spectro-
photometer at 490 nm (Mosmann, 1983), at conditions set up in our
laboratory.
2.3. Flow cytometry analysis
2.3.1. Identification of lymphocyte subpopulations
Aliquots of blood (100 μL) were hypotonically lysed twice, using
0.2% NaCl for approximately 20 s followed by addition of 1.6% NaCl to
eliminate contaminating erythrocytes. After centrifugation at 250 x g
for 8min, the cells were washed, resuspended in PBS supplemented
with 1% (v/v) FCS and incubated for 30min with a mix of the following
primary monoclonal antibodies (mAbs) CD3, CD4 and CD8, and CD21,
CD5 and CD11b. After incubation, 1mL of PBS was added to the cell
suspension and centrifuged at 250 x g for 8min. Then, cells were in-
cubated for 30min at room temperature with the labelled secondary
Abs resuspended in PBS/1% (v/v) FCS. Antibodies used are described in
Table 1. After the second incubation, cells were washed with PBS with
0.1% (v/v) bovine serum albumin and promptly analyzed by flow cy-
tometry (BD FACSCanto II, Becton Dickinson Immunocytometry
System™, San Diego, USA). Here, 20.000 cells, excluding most of the
cellular debris, were analyzed. An unstained control and single-stained
samples were also prepared as compensation controls. Negative control
samples were also stained with conjugated isotype control antibodies.
In addition, cells were stained with fluorescence minus-one (FMO)
controls. Our gating strategy analysis for B-lymphocytes subsets are
shown in supplemental Figure S1. Obtained data was analyzed with
FlowJo software (TreeStar Inc., Ashland, OR, USA). The percentages of
B- and T-lymphocytes were determined within gated peripheral blood
mononuclear cells, and their subpopulations were assessed within gated
B- or T-cells, respectively. The T-lymphocytes were divided into: T
CD4+, T CD8+ and T CD4−/CD8−.
2.3.2. Detection of apoptosis by flow cytometry
The viability of B and T lymphocytes, and their subpopulations, was
evaluated using dual labeling with an annexin-V FITC antibody
(556547, BD Biosciences, San Diego, USA) and 7-aminoactinomycin (7-
AAD; 420404, Biolend, San Diego, USA). Blood cells were labelled using
Table 1
Monoclonal antibodies used for differentiation and labeling of bovine peripheral blood lymphocytes applying flow cytometry.
Description Primary antibody Secondary
antibody
Name Type Specificity Host Company Isotype cat. n. Fluorochrome Specificity Host Company Isotype
T Lymphocyte MM1A CD3 Bovine Mouse W.S.U.1 IgG1 A31562 Alexa Fluor 680 Mouse Goat Invitrogen3 IgG1
CD4 T Lymphocyte ILA11 CD4 Bovine Mouse W.S.U.1 IgG2a 565817 BV421 Mouse Rat BD H. TM4 IgG2a
CD8 T Lymphocyte MCA837PE CD8 (PE) Bovine Mouse Bio-rad2
B Lymphocyte MCA1424PE CD21 (PE) Bovine Mouse Bio-rad2
CD5 B29A CD5 Bovine Mouse W.S.U.1 IgG2a 565817 BV421 Mouse Rat BD H. TM4 IgG2a
β2-integrin MM12A CD11b Bovine Mouse W.S.U.1 IgG1 A31562 Alexa Fluor 680 Mouse Goat Invitrogen1 IgG1
PE: R-Phycoerythrin; 1Washington State University, Pullman, WA, USA; 2Bio-rad, Raleigh, USA; 3Invitrogen, Carlsbad, CA, USA; 4BD Horizon TM, Piscataway, USA.
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mAbs as described above. To analyze the data, scatter plots were gen-
erated for the gated B and T cells, and their subpopulations. The non-
apoptotic cells were negative for the FITC-labeled annexin V and 7-AAD
staining. Cells that were reactive to FITC-labeled annexin V but nega-
tive for 7-AAD were classified as apoptotic. Finally, the cells that were
reactive for both FITC-labeled annexin V and 7-ADD were classified as
late apoptotic or necrotic.
2.3.3. Statistics analysis
For statistics analysis of results, the INFOSTAT (Córdoba, Argentina)
software was used. In cell proliferation assays, stimulation index was
calculated as the relative absorbance of mitogen-stimulated cells di-
vided by the absorbance of unstimulated (control) cells within each
group. For flow cytometry results, the normal distribution of data was
evaluated with the Kolmogorov test, and differences between groups
were evaluated using ANOVA followed by Tukey test. Results are re-
ported as means ± SD. A value of P≤ 0.05 was considered significant.
3. Results
3.1. HPL animals proliferate more than LPL and BLV-uninfected animals
When comparing infected versus with uninfected animals, the first
group showed statistically significant differences with all the tested
stimuli: ConA (P = 0.002), PWM (P = 0.007), LPS (P = 0.0008)
(Fig. 1A). A higher proliferative response was observed in HPL animals
compared to LPL, when stimulated with the mitogens ConA (P= 0.01),
PWM (P = 0.03) and LPS (P = 0.01). When BLV-uninfected and HPL
animals were compared, the BLV-uninfected dairy cows showed lower
lymphocyte proliferation stimulation index with all stimuli (ConA, P=
0.0007; PWM, P = 0.004; LPS, P = 0.0007). However, when BLV-
uninfected animals were compared with the LPL group, the prolifera-
tion response was more evident in the latter group. Proliferation rates in
LPL group were higher when stimulating with ConA (P = 0.02), PWM
(P = 0.045) and LPS (P = 0.002) (Fig.1B).
3.2. Percentages of total B- and T-lymphocytes and their subpopulations in
BLV infected animals with HPL and LPL, and BLV-uninfected animals
The percentages of B-lymphocytes CD21+, and its subpopulations
CD11b−/CD5+, CD11b+/CD5+, CD11b+/CD5−, CD11b−/CD5- were
evaluated by flow cytometry. The analysis of flow cytometry in PBMCs
from HPL, LPL and uninfected animals showed that HPL animals had a
higher percentage of B cells (P = 0.01) and CD11b−/CD5+B-lym-
phocytes (P = 0.005), compared to LPL and uninfected cattle. Also, a
larger population of CD11b−/CD5−B-lymphocytes in BLV-uninfected
animals compared to HPL animals (P = 0.003) (Fig. 2A) was found.
When a similar analysis is performed with T-lymphocytes both the
BLV-uninfected cattle and the LPL group presented a higher percentage
of CD3+ lymphocytes than those of HPL group (P = 0.01). Similar
results were observed in CD4+ T-cells (P= 0.01). However, concerning
the CD8+T-lymphocytes, this greater difference was only observed in
LPL animals compared to HPL (P= 0.01). The percentages of T CD4−/
CD8- lymphocytes had no significant differences between the groups
studied (Fig. 2B).
3.3. B-lymphocytes present greater early apoptosis rates in BLV-uninfected
dairy cows than HPL animals
As expected, the B-lymphocyte subpopulations of PBMCs from HPL
animals had a much lower percentage of cells exhibiting early apop-
tosis, which is related to the viability results detailed below. As shown
in Fig. 3A, B-lymphocytes (P= 0.009) and its subpopulations CD11b−/
CD5+ (P = 0.007) and CD11b+/CD5+ (P = 0.005) presented sig-
nificant lower early apoptosis rates than BLV-uninfected dairy cows
(Fig. 3A). Concerning early apoptosis in T-cell subpopulations, no
significant differences between groups were found (Fig. 3B).
3.4. Increased late apoptosis in CD11b+/CD5+B-lymphocytes in LPL
animals
Coincidentally, B CD11b+/CD5+ lymphocytes from LPL animals
had both higher early and late apoptosis (P = 0.03) than HPL animals.
In the case of BLV-uninfected animals, they had higher late apoptosis
compared to HPL animals in B cells (P= 0.03) (Fig. 4A). Related to the
cellular subpopulations of T-lymphocytes which are mainly in late
apoptosis, we did not find statistically significant differences between
the groups (Fig. 4B).
3.5. Increased viability in B-lymphocyte subpopulations in HPL animals
compared to LPL and BLV-uninfected dairy cows
Differences were found between HPL and LPL animals: the cells of
the former are more viable than the latter in the following lymphocyte
populations: B lymphocytes (P = 0.003) and B CD11b+/CD5+ (P =
0.004) cells. Also, differences were found between HPL and BLV-un-
infected animals: B-lymphocytes (P = 0.003) and its subpopulations
CD11b−/CD5+ (P = 0.0001), B CD11b+/CD5+ (P = 0.004) and B
CD11b−/CD5− (P = 0.04). In the case of the LPL animals, the B
CD11b-/CD5+ cells were negative for Annexin-V FITC and 7-AAD
(non-apoptotic) compared to BLV-uninfected cattle (P= 0.0001)
(Fig. 5A). Regarding the viability of T-lymphocytes and its subpopula-
tions, there were no significant differences between groups (Fig. 5B).
4. Discussion
Although BLV infection causes EBL only in less than 10% of infected
animals, recent studies suggest that it causes more negative effects on
the herd than previously believed. BLV interferes with the production
and performance of infected animals, and there are abnormalities in the
immunity of these animals (Frie and Coussens, 2015). Several studies
have focused on studying the abnormalities in cell proliferation, which
would lead to PL, finding differences in the ovine experimental model
related to the natural BLV host (Florins et al., 2008). Currently all the
studies were studied in lymphocyte proliferation in naturally BLV-in-
fected dairy cows, PL and non-PL animals (Erskine et al., 2011; Souza
et al., 2011). No study has regarded the different BLV proviral load that
may bias the previous findings, as a significant proportion of AL dairy
cows showed HPL as animals with PL (Juliarena et al., 2007). As far as
we know, the present study is the first one concerning cell proliferation
and apoptosis developed in naturally infected cattle, considering their
proviral load.
In vitro studies using mitotic stimuli on lymphocytes are aimed to
evaluate their functionality, and cells usually respond by producing
cytokines, expressing cytokine receptors, and ultimately, proliferating.
In our assays, mitogens were selected based on their proliferation effect
on different lymphocyte subpopulation: LPS and PWM mitogens both
stimulate B-lymphocytes, while ConA stimulates T-cells. Stimulated
PBMCs from HPL animals proliferate more than those from LPL and
BLV-uninfected cattle; and in turn, cells from infected animals pro-
liferate more than those from uninfected. When LPS and PWMmitogens
were used, the same groups had the same behavior as when ConA was
used. We could conclude that PBMCs from HPL animals are more sen-
sitive to cell proliferation when stimulated in vitro with different mi-
togens. Sordillo et al. showed previously that lymphocytes from PL
cattle had lower proliferative responses to ConA or PWM, compared
with cells from AL or BLV-uninfected animals (Sordillo et al., 1994).
Other data from the literature describe that, when stimulating with
ConA, cells from negative animals have greater proliferation when
compared with those from PL, and concerning stimulation with PWM,
cells from AL animals proliferate more than those from PL and unin-
fected animals (Erskine et al., 2011). Differences in results might come
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from different concentration of mitogens used in the in vitro studies.
Besides, we classify animals in terms of their proviral load, and the
group with HPL may include AL animals.
In our work, HPL animals have grater proliferation with and
without stimuli in culture than the others groups. Our results might
agree with those from Konnai et al., who reported spontaneous cell
proliferation in PBMCs from BLV-infected cattle with high percentage
of BLV-infected cell and with lymphosarcoma, and non-spontaneous
cell proliferation in PBMCs derived from cattle with low percentage of
BLV-infected cells or BLV-uninfected cattle (Konnai et al., 2006).
BLV-infected animals often show abnormal ratios of cell populations
in comparison to healthy animals: significantly higher relative B-cell
percentages and significantly lower relative T-cell percentages, in-
cluding lower percentages of CD3+, CD4+ and CD8+ cells (Erskine
et al., 2011; Sordillo et al., 1994; Van den Broeke et al., 2010) and a
higher ratio of CD4+:CD8+ T cells (Stone et al., 1995) than uninfected
controls. Based on proviral load, we found that HPL animals have a
significantly lower percentage of T-cells, both CD4+ and CD8+ cells.
Therefore, when stimulated with ConA, PBMCs from these animals tend
to proliferate less than those from LPL or negative animals. As we ob-
served that HPL animals have a higher percentage of B-cells, this could
explain why PBMCs proliferate more with LPS and PWM, compared to
the other two groups. Indeed, BLV primarily infects B-cells (Meiron
et al., 1997) and 66% of CD5+ B-cells carried the provirus (Mirsky
et al., 1996). So, as others authors suggested (Frie et al., 2017), our
results could indicate that infected B-cells proliferate in response to
immune stimulation. A key factor to be taken into account is BLV re-
activation when infected cell are in vitro cultured (Florins et al., 2007).
Even though whole PBMCs were evaluated, the high rates of pro-
liferation seen in our study could come from B-lymphocytes, which may
also proliferate due to virus reactivation in culture.
Programmed cell death (apoptosis) is a biological process for the
normal functioning of the immune system. When this mechanism is
altered due to BLV infection, the homeostasis of lymphocyte popula-
tions is altered (Debacq et al., 2003; Florins et al., 2008). Several stu-
dies on cell dynamics and apoptosis were carried out in experimentally
BLV-infected sheep (Chevallier et al., 1998; Debacq et al., 2002; Florins
et al., 2009). Moreover, concerning the natural host for the virus, most
Fig. 1. Mean ± SEM lymphoproliferative response to mitogens from PBMCs isolated from: (A) BLV-infected animals (BLV+) and BLV-uninfected animals (BLV-); (B)
in HPL, LPL and BLV-. One asterisk (*) indicates significant statistical differences (P<0.05) related to the uninfected control; two asterisks (**) indicate statistically
significant differences (P<0.05) related to LPL.
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studies were done in vitro, on cultured cells, and showed an increased
apoptosis rates in B-cells from AL cows (Cantor et al., 2001; Debacq
et al., 2003). On studies demonstrated that freshly isolated B-cells do
not have significantly different rates of apoptosis between uninfected
and BLV-infected cattle (Erskine et al., 2011). On the contrary, Souza
observed a lower lymphocyte proliferation in the animals of the LP
group associated with the reduction of CD5+ cell apoptosis (Souza
et al., 2011). We evaluated, for the first time, B- and T-lymphocytes
subpopulations, from uninfected and BLV-infected animals classified
according to their proviral load, in terms of their percentage in
peripheral blood and its stage of apoptosis and viability. Data from the
literature suggest that the target cell for BLV is MHCII+, IgM+, CD5+
and CD11b+ with some fluctuations for the three latter markers at late
stages of the disease (Gillet et al., 2007). We show that the percentage
of CD11b+/CD5+ cells is increased in HPL animals compared to LPL
and no infected animals, although without significant differences. Della
Libera et al. indicate that BLV infected animals have increased values
for CD21, CD5 and CD11b markers (Della Libera et al., 2012), phe-
nomena that might be related to the modulation of apoptosis in these
cells (Souza et al., 2011). As in humans and mice, bovine CD5 molecule
Fig. 2. Percentage of B-lymphocytes (A) or T-
lymphocytes (B) and its subpopulations from
BLV-uninfected and BLV-infected animals with
low proviral load (LPL) and high proviral load
(HPL). One asterisk (*) indicates significant
difference to BLV-uninfected animals
(P<0.05); two asterisks (**) indicate statisti-
cally significant differences to LPL animals
(P<0.05); three asterisks (***) indicate sta-
tistically significant differences to HPL animals
(P<0.05).
Fig. 3. Percentage of early apoptosis in B-
lymphocytes (A) or in T-lymphocytes (B) and
their subpopulations from BLV-uninfected and
BLV-infected animals with low proviral load
(LPL) and high proviral load (HPL). One as-
terisk (*) indicates significant difference com-
pared to not infected animals (P<0.05); two
asterisks (**) indicate statistically significant
differences to LPL animals (P<0.05); three
asterisks (***) indicate statistically significant
differences to HPL animals (P<0.05).
M.V. Nieto Farias et al. Veterinary Immunology and Immunopathology 206 (2018) 41–48
45
is present in most T-cells but only in a small number of normal B-cells;
however, in BLV-infected PL cattle, nearly all of the B-cells are CD5+
(Depelchin et al., 1989). In B-cells from uninfected animals, CD5+ as-
sociates with the B-cell receptor (BCR), and this crosslinking decreases
apoptosis of CD5+ B-cells. However, CD5 is dissociated from de BCR in
B-cells from PL cattle and it was suggested that subsequent decreased
apoptosis in antigenically stimulated B-cells may thus be a mechanism
of BLV induced PL (Hamilton et al., 2003; Gillet et al., 2007). Another
marker, the CD11b integrin molecule, was also observed in infected
animals from several studies (Gillet et al., 2007). In our study,
CD11b+/CD5+ cells population from HPL animals have a higher per-
centage of cell viability with respect to the other two groups, which is
accompanied by a decrease in early and late apoptosis. These results
would be in accordance with data from the literature, where lympho-
cyte immune phenotyping of BLV-infected cows with PL had an in-
crease in B-cells, mainly B CD5+/CD11b+, due to apoptosis inhibition
(Blagitz et al., 2017). Moreover, Erskine et al. showed that PL animals
have an increased expression of the anti-apoptotic gene Bcl2, and AL
animals had higher expression of the pro-apoptotic gene Bcl2L1
(Erskine et al., 2011).
When analyzing the other B-cell subpopulations, the markers that
are increased in HPL animals compared to non-infected animals are
CD21+ and CD11b−/CD5+. In addition, these cells have a higher
percentage of viability, and a decrease in early apoptosis. This could be
Fig. 4. Percentage of late apoptosis in B-lym-
phocytes (A) or in T-lymphocytes (B) and their
subpopulations from BLV-uninfected and BLV-
infected animals with low proviral load (LPL)
and high proviral load (HPL). One asterisk (*)
indicates significant difference related, com-
pared, to not infected animals (P<0.05); two
asterisks (**) indicate statistically significant
differences to LPL animals (P<0.05); three
asterisks (***) indicate statistically significant
differences to HPL animals (P<0.05).
Fig. 5. Percentage of viability in B-lympho-
cytes (A) or in T-lymphocytes (B) and their
subpopulations from BLV-uninfected and BLV-
infected animals with low proviral load (LPL)
and high proviral load (HPL). One asterisk (*)
indicates significant difference to not infected
animals (P<0.05); two asterisks (**) indicate
statistically significant differences to LPL ani-
mals (P<0.05); three asterisks (***) indicate
statistically significant differences to HPL ani-
mals (P<0.05).
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a manifestation that BLV infection also alters the balance of cell death
and proliferation in other lymphocyte populations such as CD21+ and
CD11b−/CD5+. When uninfected and LPL animals were compared, no
differences in the viability, total percentage and apoptosis were found
in CD11b+/CD5+ and CD21+ cells. On the contrary, we observed a
slight increase in the percentage of cell viability of the CD11b−/CD5-
cells in LPL animals.
Our results show that HPL animals have an imbalance in terms of
programmed cell death and cell viability in cells that are target of BLV.
In fact, LPL animals have increased apoptosis rates in this cellular
subpopulation. In turn, the main difference between BLV-uninfected
and LPL animals is that the latter have a higher percentage of late
apoptosis compared to HPL. Therefore, this could be specifically the
way by which LPL animals control the progression of the disease.
Regarding population of T-lymphocytes, other authors showed that
PL animals have a lower counting in the absolute number of T-cells,
both CD4+ and CD8+, in comparison with AL or uninfected animals
(Gatei et al., 1989). However, Della Libera et al. described no sig-
nificant changes in the absolute numbers of CD4+ and CD8+T-lym-
phocytes in PL animals, but with a lower percentage of both subsets
(Della Libera et al., 2012). In this way, we found that LPL animals have
a higher percentage of CD3+, CD4+ and CD8+T-lymphocytes than
HPL animals.
The proportion of CD4+ and CD8+ T cells can be related to the
differential secretion of cytokines in the groups of animals. Indeed,
cytokines expression in response to BLV infection is deregulated, with a
prevalence of a Th1 profile observed in animals with lymphosarcoma
and PL. This imbalance and suppression of T-cell proliferation in re-
sponse to BLV antigens are considered to be associated with disease
progression (Orlik and Splitter, 1996; Trainin et al., 1996; Pyeon and
Splitter, 1998; Yakobson et al., 2000; Kabeya et al., 2001; Frie and
Coussens, 2015). Our previous studies showed that expression of IFN-γ
(Th1 cytokine) is higher in LPL animals (Farias et al., 2016), indicating
a protective role of IFN-γ in the pathogenesis of BLV infection. This
cytokine mediates the activation of NK cells, monocytes/macrophages
and dendritic cells; it promotes the differentiation of CD4+ T-cells into
a Th1 profile and the activation of T CD8+ cells, in favors of the de-
velopment of an effective antiviral immunity. In turn, as a positive
feedback, IFN-γ is secreted by γδ+ T-cells and NK cells, CD4+ Th1 cells
and cytotoxic CD8+ T-cells, monocytes/macrophages and dendritic
cells (Schroder et al., 2004). The largest proportion of CD4+ and CD8+
T lymphocytes found in our LPL animals reinforces the concept of a
better capability of these animals to eradicate/control BLV infection,
may be via strong cytotoxic responses positively regulated by IFN-γ. As
mentioned, γδ+ T-cells and NK cells are major IFN-γ sources and they
have also cytotoxic functions. Clevers et al. defined the bovine T CD4-/
CD8- population as γδ+ T-lymphocytes (Clevers et al., 1990). It has
been described that the state of AL in BLV infection is related to a
greater proportion of γδ+ T-lymphocytes (Lundberg and Splitter,
2000). However, in our study no differences were found in the per-
centage of T CD4-/CD8- population. Thus, the higher expression of IFN-
γmRNA found in LPL animals (Farias et al., 2016) might not come from
those cells, but it could be related to a greater cytotoxic CD8+ cell, NK
cell or professional antigen-presenting cell percentage in these animals.
LPL animals presented a higher percentage of apoptosis in CD11b+/
CD5+ B-lymphocytes, which are the primary targets for BLV integration
(Meiron et al., 1997). These data, in turn, are related to the high per-
centage of viability of the B subpopulations of LPL animals. This re-
inforces the concept that LPL animals have an anti-apoptotic and pro-
liferative status.
Our work confirmed that BLV infection alters cellular homeostasis,
and it turns in a deficiency of the immune system in infected animals.
Indeed, in agreement with our findings, a functional exhaustion of
CD4+ and CD8+ T cells, associated to disease development has been
demonstrated (Okagawa et al., 2018). Thus, infected animals are less
competent to fight against other diseases, which generates significant
economic losses. The only way to eradicate BLV infection would be to
sacrifice positive animals. As there are no economic compensation po-
licies in our country, we suggest that one way to control the infection
would be replacing HPL animals with LPL animals since they behave
like “controlling animals”. At the same time, it would be interesting to
know which proteins are involved in the apoptosis of these animals, in
order to accurately identify how the BLV alters its target cells.
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